Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART.

@article{Weintrob2008IncreasingAA,
  title={Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART.},
  author={Amy C. Weintrob and Ann M. Fieberg and Brian K. Agan and Anuradha Ganesan and Nancy F. Crum-Cianflone and Vincent C. Marconi and Mollie Poehlman Roediger and Susan L. Fraser and Scott A Wegner and Glenn W. Wortmann},
  journal={Journal of acquired immune deficiency syndromes},
  year={2008},
  volume={49 1},
  pages={40-7}
}
BACKGROUND Studies evaluating the effect of age on response to highly active antiretroviral therapy (HAART) have been limited by their inability to control for duration of human immunodeficiency virus (HIV) infection. We examined the effect of age at HIV seroconversion on response to HAART. METHODS A retrospective analysis of a longitudinal US military… CONTINUE READING